How much is a shire share worth?
One share of SHPG stock can currently be purchased for approximately $179.20. How much money does Shire make? Shire has a market capitalization of $54.71 billion and generates $15.16 billion in revenue each year. The biopharmaceutical company earns $4.27 billion in net income (profit) each year or $15.15 on an earnings per share basis.
What are analysts'price targets for Shire stock?
4 equities research analysts have issued 1-year price targets for Shire's stock. Their predictions range from $222.00 to $222.00. On average, they expect Shire's share price to reach $222.00 in the next year. View Analyst Price Targets for Shire.
What does Shire do for a living?
Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.
Is Shire's PEG ratio overvalued?
Shire has a PEG Ratio of 1.54. PEG Ratios above 1 indicate that a company could be overvalued. Shire has a P/B Ratio of 1.50.
How were Shire's earnings last quarter?
Shire plc (NASDAQ:SHPG) announced its quarterly earnings data on Thursday, April, 26th. The biopharmaceutical company reported $3.86 earnings per s...
Is Shire a good dividend stock?
Shire(NASDAQ:SHPG) pays an annual dividend of $0.34 per share and currently has a dividend yield of 0.19%. The dividend payout ratio of Shire is 2....
Who are Shire's key executives?
Shire's management team includes the following people: Dr. Flemming Ornskov M.P.H. , MBA, M.D., MPH, CEO, MD & Exec. Director (Age 60) Mr. Thoma...
Who are some of Shire's key competitors?
Some companies that are related to Shire include Abbott Laboratories (ABT) , AstraZeneca (AZN) , Novartis (NVS) , Bristol-Myers Squibb (BMY) ,...
What other stocks do shareholders of Shire own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Shire investors own include Gilead Sciences (GILD) , Inte...
What is Shire's stock symbol?
Shire trades on the NASDAQ under the ticker symbol "SHPG."
What is Shire's stock price today?
One share of SHPG stock can currently be purchased for approximately $179.20.
How much money does Shire make?
Shire (NASDAQ:SHPG) has a market capitalization of $54.71 billion and generates $15.16 billion in revenue each year. The biopharmaceutical company...
How can I contact Shire?
Shire's mailing address is BLOCK 2 MIESIAN PLAZA 50-58 BAGGOT STREET LOWER, Dublin L2, D02 . The official website for Shire is www.shire.com . Th...
How were Shire's earnings last quarter?
Is Shire a good dividend stock?
Shire plc (NASDAQ:SHPG) released its quarterly earnings results on Thursday, April, 26th. The biopharmaceutical company reported $3.86 earnings per share for the quarter, beating the consensus estimate of $3.58 by $0.28. The biopharmaceutical company had revenue of $3.77 billion for the quarter.
Who are some of Shire's key competitors?
Shire pays an annual dividend of $0.34 per share and currently has a dividend yield of 0.19%. The dividend payout ratio of Shire is 2.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Shire will have a dividend payout ratio of 2.15% next year.
What other stocks do shareholders of Shire own?
Some companies that are related to Shire include Abbott Laboratories (ABT), Novartis (NVS), Merck & Co., Inc.
What is Shire's stock price today?
Based on aggregate information from My MarketBeat watchlists, some companies that other Shire investors own include Gilead Sciences (GILD), Intel (INTC), (CELG), Merck & Co., Inc. (MRK), Cisco Systems (CSCO), Walt Disney (DIS), Johnson & Johnson (JNJ), Pfizer (PFE), Starbucks (SBUX) and Exxon Mobil (XOM).
How much money does Shire make?
One share of SHPG stock can currently be purchased for approximately $179.20.
Where are Shire's headquarters?
Shire has a market capitalization of $54.71 billion and generates $15.16 billion in revenue each year. The biopharmaceutical company earns $4.27 billion in net income (profit) each year or $15.15 on an earnings per share basis.
